about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersStakeholder engagement in policy development: challenges and opportunities for human genomicsCancer screening and genetics: a tale of two paradigmsPersonalised medicine in the UK: challenges of implementation and impact on healthcare system.'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq ProjectTargeted Cancer Screening in Average-Risk Individuals.Knowledge integration at the center of genomic medicine.Elevated blood pressure: Our family's fault? The genetics of essential hypertension.Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds.The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.The future of clinical cancer genomics.The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer.Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.New challenges of public health: bringing the future of personalised healthcare into focus.From public health genomics to precision public health: a 20-year journey.Providing Unrestricted Access to Prenatal Testing Does Not Translate to Enhanced Autonomy.
P2860
Q22330767-C189B017-A595-4C48-AD8B-C63300A1D05DQ28607745-3F67DE20-4ABB-4412-8169-CA2505E68FC8Q33717364-AB4AC6EF-1920-4D98-A36E-1319A11AADE7Q33772602-97FA1E33-EC16-4298-9AED-FDC4E18E87D1Q35012563-18DBBB92-6406-46D7-9453-688FDCC7F5D9Q36190584-B13A5C8A-70C6-4E27-9B1A-B4FB85FB73A5Q36377746-F915FAAC-CA17-41E3-AEB5-FA1520C0A877Q38221500-EB829D26-EAFE-488A-9825-7DB650CFB256Q38248763-E098F61F-652B-45B9-B7F5-B0B87D1D9AD9Q38392363-046757D3-5EF7-4732-9E73-321447C4EDE6Q38789283-AAD9D21F-B7CF-43CD-B1C7-B17C6CA8139BQ39150032-67C9F78C-35B8-4306-87C8-9974278269CAQ41063959-161E53E4-B90F-4DB4-989B-56B3176541E8Q43500764-1574035F-019E-4541-9946-898FB9D364E3Q47803376-E829E74D-3135-46B3-A851-CCF0AF6DFC76Q49841808-D5BBAC52-E4EF-4D98-94DB-E6290810C807Q53840231-ACFBC0F7-DE61-4B25-B924-320C2B02BF68
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The EGAPP initiative: lessons learned.
@en
type
label
The EGAPP initiative: lessons learned.
@en
prefLabel
The EGAPP initiative: lessons learned.
@en
P2860
P356
P1433
P1476
The EGAPP initiative: lessons learned.
@en
P2093
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
P2860
P2888
P304
P356
10.1038/GIM.2013.110
P407
P577
2013-08-08T00:00:00Z